Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,686 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.
Koren MJ, Giugliano RP, Raal FJ, Sullivan D, Bolognese M, Langslet G, Civeira F, Somaratne R, Nelson P, Liu T, Scott R, Wasserman SM, Sabatine MS; OSLER Investigators. Koren MJ, et al. Among authors: nelson p. Circulation. 2014 Jan 14;129(2):234-43. doi: 10.1161/CIRCULATIONAHA.113.007012. Epub 2013 Nov 19. Circulation. 2014. PMID: 24255061 Clinical Trial.
Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome.
Blom DJ, Koren MJ, Roth E, Monsalvo ML, Djedjos CS, Nelson P, Elliott M, Wasserman SM, Ballantyne CM, Holman RR. Blom DJ, et al. Among authors: nelson p. Diabetes Obes Metab. 2017 Jan;19(1):98-107. doi: 10.1111/dom.12788. Epub 2016 Oct 14. Diabetes Obes Metab. 2017. PMID: 27619750 Clinical Trial.
Rationale and design of LAPLACE-2: a phase 3, randomized, double-blind, placebo- and ezetimibe-controlled trial evaluating the efficacy and safety of evolocumab in subjects with hypercholesterolemia on background statin therapy.
Robinson JG, Rogers WJ, Nedergaard BS, Fialkow J, Neutel JM, Ramstad D, Somaratne R, Legg JC, Nelson P, Scott R, Wasserman SM, Weiss R. Robinson JG, et al. Among authors: nelson p. Clin Cardiol. 2014 Apr;37(4):195-203. doi: 10.1002/clc.22252. Epub 2014 Jan 30. Clin Cardiol. 2014. PMID: 24481874 Free PMC article. Clinical Trial.
Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.
Robinson JG, Nedergaard BS, Rogers WJ, Fialkow J, Neutel JM, Ramstad D, Somaratne R, Legg JC, Nelson P, Scott R, Wasserman SM, Weiss R; LAPLACE-2 Investigators. Robinson JG, et al. Among authors: nelson p. JAMA. 2014 May 14;311(18):1870-82. doi: 10.1001/jama.2014.4030. JAMA. 2014. PMID: 24825642 Clinical Trial.
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage.
Nguyen JK, Harik LR, Klein EA, Li J, Corrigan D, Liu S, Chan E, Hawley S, Auman H, Newcomb LF, Carroll PR, Cooperberg MR, Filson CP, Simko JP, Nelson PS, Tretiakova MS, Troyer D, True LD, Vakar-Lopez F, Weight CJ, Lin DW, Brooks JD, McKenney JK. Nguyen JK, et al. Among authors: nelson ps. Histopathology. 2024 Jun 3. doi: 10.1111/his.15231. Online ahead of print. Histopathology. 2024. PMID: 38828674
Beyond active learning: Using 3-Dimensional learning to create scientifically authentic, student-centered classrooms.
Cooper MM, Caballero MD, Carmel JH, Duffy EM, Ebert-May D, Fata-Hartley CL, Herrington DG, Laverty JT, Nelson PC, Posey LA, Stoltzfus JR, Stowe RL, Sweeder RD, Tessmer S, Underwood SM. Cooper MM, et al. Among authors: nelson pc. PLoS One. 2024 May 31;19(5):e0295887. doi: 10.1371/journal.pone.0295887. eCollection 2024. PLoS One. 2024. PMID: 38820334 Free PMC article.
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.
Newcomb LF, Schenk JM, Zheng Y, Liu M, Zhu K, Brooks JD, Carroll PR, Dash A, de la Calle CM, Ellis WJ, Filson CP, Gleave ME, Liss MA, Martin F, McKenney JK, Morgan TM, Tretiakova MS, Wagner AA, Nelson PS, Lin DW. Newcomb LF, et al. Among authors: nelson ps. JAMA. 2024 May 30:e246695. doi: 10.1001/jama.2024.6695. Online ahead of print. JAMA. 2024. PMID: 38814624
Venous Anatomy of the Central Nervous System.
Shapiro M, Chung C, Sharashidze V, Nossek E, Nelson PK, Raz E. Shapiro M, et al. Among authors: nelson pk. Neurosurg Clin N Am. 2024 Jul;35(3):273-286. doi: 10.1016/j.nec.2024.03.001. Epub 2024 Apr 6. Neurosurg Clin N Am. 2024. PMID: 38782520 Review.
2,686 results